Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen

被引:1
作者
Isha, Shahin [1 ]
Olaizola, Gustavo [2 ,3 ]
Bisso, Indalecio Carboni [2 ]
Raavi, Lekhya [1 ]
Jonna, Sadhana [1 ]
Jenkins, Anna [1 ]
Hanson, Abby [1 ]
Kashyap, Rahul [1 ,4 ]
Monzon, Veronica [5 ]
Huespe, Ivan A. [2 ,3 ]
Sanghavi, Devang [1 ]
机构
[1] Mayo Clin, Jacksonville, FL USA
[2] Hosp Italiano Buenos Aires, Buenos Aires, Argentina
[3] Univ Buenos Aires, Buenos Aires, Argentina
[4] Well Span Hlth, York, PA USA
[5] Hosp Italiano Agustin Roca, Buenos Aires, Argentina
关键词
ARDS; coronavirus disease 2019; high-flow nasal cannula oxygen; oxygen saturation; critical care; RESPIRATORY-DISTRESS-SYNDROME;
D O I
10.4187/respcare.11933
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> among non-intubated subjects with ARDS. Methods: This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 315 [with S<INF>pO<INF>2</INF></INF> <= 97%] or a P<INF>aO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 300 mm Hg while receiving >= 30 L/min O<INF>2</INF> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> cutoff proposed in the new ARDS definition, and mortality. Results: Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (n = 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (n = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (n = 98). Additionally, the worst S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (n = 177) for subjects with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 148, 17% (95% CI 12-23) (n = 38) for those with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> between 149-234, and 16% (95% CI 8-28) (n = 10) for subjects maintaining an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> higher than 235 (P < .001). Conclusions: The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [31] Associated Factors of High Sedative Requirements within Patients with Moderate to Severe COVID-19 ARDS
    Flinspach, Armin N.
    Booke, Hendrik
    Zacharowski, Kai
    Balaban, Uemniye
    Herrmann, Eva
    Adam, Elisabeth H.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [32] Clinical Practice of High-Flow Nasal Cannula Therapy in ARDS Patients: A Cross-Sectional Survey of Respiratory Therapists
    Alyami, Mohammed M.
    Aldhahir, Abdulelah M.
    Alqarni, Abdullah A.
    Salwi, Khalid M.
    Sarhan, Abdullah M.
    Almeshari, Mohammed A.
    Alobaidi, Nowaf Y.
    Alqahtani, Jaber S.
    Siraj, Rayan A.
    Alsulayyim, Abdullah S.
    Alghamdi, Saeed M.
    Alasimi, Ahmed H.
    Alqarni, Omar A.
    Majrshi, Mansour S.
    Alwafi, Hassan
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2024, 17 : 1401 - 1411
  • [33] Sequential Application of Oxygen Therapy via High-flow Nasal Cannula and Non-invasive Ventilation in COVID-19 Patients with Acute Respiratory Failure in the Intensive Care Unit: A Prospective, Observational Study
    Erdogan, Cem
    Ciftci, Bahadir
    Kizilaslan, Deniz
    Ayar, Isilay
    Topgul, Tamara Buruk
    Alver, Selcuk
    Demiraran, Yavuz
    Celik, Erkan Cem
    TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI, 2023, 21 (03): : 220 - 227
  • [34] The Role of High Flow Nasal Cannula in COVID-19 Associated Pneumomediastinum and Pneumothorax
    Simioli, Francesca
    Annunziata, Anna
    Polistina, Giorgio Emanuele
    Coppola, Antonietta
    Di Spirito, Valentina
    Fiorentino, Giuseppe
    HEALTHCARE, 2021, 9 (06)
  • [35] Usage of high-flow oxygen therapy outside the intensive care unit: a possibility to delay or prevent the need for mechanical ventilation among COVID-19 patients
    Andras, Beres
    Katalin, Orban
    Zsolt, Szinku
    Gyorgy, Kover
    Krisztina, Szabo
    Erzsebet, Papp
    Janos, Fogas
    ORVOSI HETILAP, 2022, 163 (07) : 254 - 266
  • [36] Severe Patients With ARDS With COVID-19 Treated With Extracorporeal Membrane Oxygenation in China: A Retrospective Study
    Lai, Wei
    Li, Shuanglei
    Du, Zhongtao
    Ma, Xinhua
    Lu, Junyu
    Gao, Wei Dong
    Abbott, Geoffrey W.
    Hu, Zhaoyang
    Kang, Yan
    FRONTIERS IN MEDICINE, 2021, 8
  • [37] Comparison of high-flow nasal oxygen cannula therapy versus a standard oxygen face mask in patients with hypostatic pneumonia
    Song, Yamei
    Zhang, Jinchao
    Xing, Jia
    Wang, Ning
    Wang, Jing
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (06)
  • [38] Pros of prone positioning with high-flow nasal oxygenation in morbidly obese patients with moderate-to-severe COVID-19 acute respiratory distress syndrome: A retrospective analysis
    Wadhawa, Reema
    Trivedi, Visharad
    Singh, Anisha
    Bhalotra, Anju Romina
    Wadhawa, Vivek
    Shah, Pratik
    Jadav, Deepa
    INDIAN ANAESTHETISTS FORUM, 2022, 23 (01) : 68 - 72
  • [39] Association of plasma volume status with outcomes in hospitalized Covid-19 ARDS patients: A retrospective multicenter observational study
    Balasubramanian, Prasanth
    Isha, Shahin
    Hanson, Abby J.
    Jenkins, Anna
    Satashia, Parthkumar
    Balavenkataraman, Arvind
    Huespe, Ivan A.
    Bansal, Vikas
    Caples, Sean M.
    Khan, Syed Anjum
    Jain, Nitesh K.
    Kashyap, Rahul
    Cartin-Ceba, Rodrigo
    Nates, Joseph L.
    Reddy, Dereddi R. S.
    Milian, Ricardo Diaz
    Farres, Houssam
    Martin, Archer K.
    Patel, Parag C.
    Smith, Michael A.
    Shapiro, Anna B.
    Bhattacharyya, Anirban
    Chaudhary, Sanjay
    Kiley, Sean P.
    Quinones, Quintin J.
    Patel, Neal M.
    Guru, Pramod K.
    Franco, Pablo Moreno
    Sanghavi, Devang K.
    JOURNAL OF CRITICAL CARE, 2023, 78
  • [40] Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study
    Kovacevic, Pedja
    Milakovic, Dragana
    Kovacevic, Tijana
    Barisic, Vedrana
    Dragic, Sasa
    Zlojutro, Biljana
    Miljkovic, Branislava
    Vucicevic, Katarina
    Rizwan, Zeeshan
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (10) : 7747 - 7756